CATRENE Programme to Succeed MEDEA+ as European Nanoelectronics R&D Champion

MEDEA+, the EUREKA pan-European Programme for advanced co-operative Research and Development in Microelectronics, today announced details of the new EUREKA programme called CATRENE (Cluster for Application and Technology Research in Europe on NanoElectronics) that will take up the challenge of increasing Europe's strength in micro- and nanoelectronics after the highly successful MEDEA+ programme reaches its conclusion in 2008. A public/private partnership aimed at ensuring the continued development of European expertise in semiconductor technology and applications, CATRENE will build on the success of MEDEA+ and the previous EUREKA programmes JESSI and MEDEA in fostering the continued development of a dynamic European ecosystem with the critical mass necessary to compete at a global level in high technology industries as these move into the era of nanoelectronics.

Since its inception in 2001, MEDEA+ has made significant contributions to establishing and maintaining European leadership in fields ranging from smart card and image sensing technologies to automotive electronics. European IC companies have successfully developed three basic CMOS process generations in a time schedule in line with or even ahead of the global ITRS roadmap. Three European semiconductor companies are ranked amongst the world wide top ten and Europe's semiconductor industry has 10% of the world wide market. European champions with a strong global market position as wafer processing equipment suppliers, lithography tool and infrastructure suppliers as well as substrate and material suppliers have been added to the industrial landscape.

Like MEDEA+, CATRENE embraces all key actors in the value chain - including applications, technology, materials and equipment suppliers - as well as involving industrial companies of all sizes, universities and other research institutions, supported by Public Authorities. In this way CATRENE will benefit from the strong infrastructure for cross-border cooperation that has been developed by MEDEA+ and its predecessors.

An important feature of CATRENE is the concept of Lighthouse Projects, which address major socioeconomic needs such as transportation, healthcare, security, energy and entertainment through focussed R&D programmes. In the foreseeable future, the role of electronics and information systems will further increase as European society is faced with structural problems such as ageing of the population, exploding healthcare cost, transportation bottlenecks, rising energy costs and the need to increase productivity to be competitive on a worldwide basis. These societal challenges are also major opportunities for European industry and are designed to help European companies to address these new lead markets and to become worldwide market leaders. The "umbrella" lighthouse projects will serve as a focus for specific technology and applications development projects that address these challenges.

"For more than a decade, the EUREKA JESSI, MEDEA and MEDEA+ programmes have made it possi-ble for Europe's industry to reinforce its position in semiconductor process technology, manufac-turing and applications, and to become a key supplier to markets such as telecommunications, consumer electronics and automotive electronics", said Jozef Cornu, Chairman of MEDEA+ and designated Chairman of CATRENE. "Nanoelectronics will offer enormous opportunities to those who are the first to master and bring to market new technologies and applications and we believe that CATRENE will play a vital role in helping Europe's microelectronics industry to go from strength to strength."

While the JESSI, MEDEA and MEDEA+ programmes were divided into technology and applications sub-programmes, CATRENE recognises the increasing convergence of technology and applications. It will therefore focus on large identified application markets, deriving from these the roadmap of required technologies. Key technology goals include maintaining and increasing Europe's strength in IP (Intellectual Property) across the entire electronics supply chain and its leadership in lithography and Silicon-on-Insulator materials; ensuring that European companies are among the world leaders in the advanced semiconductor technologies that allow entire systems to be integrated in a single package; and strengthening European expertise in applying a deep knowledge of semiconductor process technology to efficient design for new electronics applications.

For more information on MEDEA+ and CATRENE visit http://www.medeaplus.org.

About MEDEA+
The MEDEA+ programme (2001-2008) comprised 77 projects involving 20,000 person-years and around 450 partner organisations from large companies (38 %), SMEs (37%), institutes and academia (25%). It delivered important innovations in key application areas such as automotive and traffic control, broadband communications, secure society, energy saving and healthcare.

About CATRENE
CATRENE is a four-year programme, starting 1 January 2008 and extendable by another four years. This is in line with the changing landscape of the semiconductor industry as well as the present view on technology evolution and the time span over which most of the major applications will develop. Resources required will be annually around 4,000 person-years, equalling about € 6 billion for the extended programme.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...